Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes-insights that could help doctors ...

Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ... squamous cell carcinoma, small-cell carcinoma, and large-cell ...

As part of its continued commitment to developing next-generation cancer therapeutics, Ocean Biomedical is initiating ...

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.

Scientists believe that air pollution could be a major cause behind the rise in global lung cancer cases in people that have ...

Collaboration focuses on launching an AI-powered biomarker prediction panel targeting actionable biomarkers to revolutionize lung cancer diagnostics and enable commercialization of a diagnostic panel.